Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Conditions: Human Papilloma Virus Interventions: Biological: Gardasil 9 Sponsors: University of Alabama at Birmingham; Merck Investigator Studies Program Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cervical Cancer Vaccine | Emergency Medicine | Gardasil | Human Papillomavirus (HPV) | Merck | Research | Study | Vaccines